Patents by Inventor David Lankin

David Lankin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclic peptide from sp., process for the production thereof, and pharmaceutical composition for the prevention or treatment of mycobacteria related disease comprising the same
    Patent number: 9090667
    Abstract: The present invention relates to novel anti-TB cyclic peptides from Nonomuraea sp. MJM5123, a process for the production of the anti-Tuberculosis peptide and a pharmaceutical composition for the prevention and treatment of mycobacterial infection comprising the same. The composition of the present invention is highly active against replicating/non-replicating M. tuberculosis, including MDR and XDR strains, so that it can be effectively used as a therapeutic agent for tuberculosis.
    Type: Grant
    Filed: April 18, 2012
    Date of Patent: July 28, 2015
    Assignees: Myongji University Industry and Academia Cooperation Foundation, The Board of Trustees of the University of Illinois
    Inventors: Jong Woo Kim, Sang Wook Lee, Sang Jin Park, Joo Won Suh, In Ae Lee, Tae Mi Yoon, Jong Keun Choi, Ji Ean Lee, Jin Yong Kim, Ying Yu Jin, Scott Franzblau, Sanghyun Cho, Wei Gao, Guido Pauli, James McAlpine, Jose Napolitano, Birgit Jaki, Brent Friesen, Maria Florencia Rodriguez Brasco, David Lankin
  • CYCLIC PEPTIDE FROM NONOMURAEA SP., PROCESS FOR THE PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF MYCOBACTERIA RELATED DISEASE COMPRISING THE SAME
    Publication number: 20140142031
    Abstract: The present invention relates to novel anti-TB cyclic peptides from Nonomuraea sp. MJM5123, a process for the production of the anti-Tuberculosis peptide and a pharmaceutical composition for the prevention and treatment of mycobacterial infection comprising the same. The composition of the present invention is highly active against replicating/non-replicating M. tuberculosis, including MDR and XDR strains, so that it can be effectively used as a therapeutic agent for tuberculosis.
    Type: Application
    Filed: April 18, 2012
    Publication date: May 22, 2014
    Inventors: Jong Woo Kim, Sang Wook Lee, Sang jin Park, Joo Won Suh, In Ae Lee, Tae Mi Yoon, Jong Keun Choi, Ji Ean Lee, Jin Yong Kim, Ying Yu Jin, Scott Franzblau, Sanghyum Cho, Wei Gao, Guido Pauli, James McAlpine, Jose Napolitano, Birgit Jaki, Brent Friesen, Maria Florencia Rodriguez Brasco, David Lankin
  • Nuclear Magnetic Resonance Method for Quantitative and Qualitative Measurement of Natural Products
    Publication number: 20100315083
    Abstract: Provided herein are various methods and systems for analyzing natural products by quantitative proton nuclear magnetic resonance (qHNMR). A method is provided for quantitative and qualitative determination of a natural product by 1HNMR and decoupling 13C nuclei from the protons in the sample containing the natural product. The resultant spectrum wherein the decoupling provides a cleaner spectrum is used to provide both structural and quantitative information about species within the sample. In an aspect, the decoupling is provided by globally optimized alternating-phase rectangular pulses (GARP). The methods presented herein are optionally used to detect impurities in a reference material and verify the purity level of a reference material.
    Type: Application
    Filed: October 19, 2007
    Publication date: December 16, 2010
    Applicant: The Board of Trustees of the University of Illinois
    Inventors: Guido F. Pauli, Birgit Jaki, David Lankin